JNJ’s Business Review Day Highlights Company Priorities and Restructuring

Johnson & Johnson/JNJ’s business review day on May 18 filled some gaps in my understanding of the restructuring picture, but some holes remain. Here’s what I learned, and what we don’t know yet.

First, a quick rewind. In January 2016, JNJ announced restructuring actions intended to affect the Medical Devices unit, wherein...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us